Atherosclerosis from Newborn to Adult-Epidemiology, Pathological Aspects, and Risk Factors

Alina Costina Luca1, Simona Georgiana David2, Alexandru Gabriel David2

  • 1Pediatrics Department, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.

Life (Basel, Switzerland)
|October 28, 2023
PubMed

Insights

Atherosclerosis, a chronic inflammatory disease, begins in childhood and is a major cause of cardiovascular disease deaths. Early identification of risk factors like dyslipidemia and obesity in children is crucial for prevention.

Area of Science:

  • Cardiovascular Medicine
  • Pediatric Pathology
  • Immunology

Background:

  • Cardiovascular disease (CVD) is the leading global cause of mortality, with atherosclerosis underlying most cases.
  • Atherosclerosis is a chronic, immune-inflammatory process initiating in childhood with fatty streaks and progressing to complex plaques.
  • Plaque rupture leading to coronary thrombosis is a common cause of CVD mortality, with increasing global prevalence.

Purpose of the Study:

  • To review the current understanding of atherosclerosis origin and progression in childhood.
  • To identify known risk factors for atherosclerotic cardiovascular disease in pediatric populations.

Main Methods:

  • This review synthesizes information from epidemiological studies and existing literature.
  • Focuses on the early pathological changes and identified risk factors in children.

Main Results:

  • Atherosclerosis begins in childhood, characterized by lipid and inflammatory cell accumulation in arteries.
  • Key risk factors identified include dyslipidemia, hypertension, diabetes mellitus, obesity, and smoking.
  • These factors contribute to the early pathogenic foundation for atherosclerosis.

Conclusions:

  • Atherosclerosis is an early-onset disease with significant long-term cardiovascular implications.
  • Understanding childhood risk factors is essential for preventing adult cardiovascular disease.
  • Further research and early intervention strategies are needed for pediatric populations.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
9
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
11
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
17
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
17
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12